Protein Metrics And Protea Biosciences, Inc. Announce Collaborative Partnership

SAN CARLOS, Calif., Feb. 17, 2016 /PRNewswire-iReach/ -- Protein Metrics Inc., a premier provider of software solutions for comprehensive characterization of proteins, and Protea Biosciences, a leader in Bioanalytical Sciences have today announced a collaboration to advance the analysis of protein biotherapeutics.

Photo - http://photos.prnewswire.com/prnh/20160215/333081

Protea is a leading service provider to the biopharmaceutical industry concentrating on the efficient characterization of biotherapeutics.  Protein Metrics supplies software that increases the confidence of assignment and accurate quantification of quality attributes.  As a result of this collaboration, Protein Metrics will provide Protea access to its advanced suite of software for comprehensive protein characterization, PTM analysis, and sequence variant analysis.  Protea will leverage its range of mass spectrometric analysis tools and expertise in combination with Protein Metrics software to provide efficient, 'deep-dive' services to identify, characterize, and quantify attributes of biologically important molecules to support the pharmaceutical industry's research and development objectives.

"We are positioning Protea to be a leader in the next generation of bioanalytics, focused on the needs of the biotherapeutics industry. Toward that end we recently announced our collaboration with Protein Metrics", stated Greg Kilby, Ph.D., Protea's Vice President and Chief Operating Officer. He added, "Our Protein Metrics collaboration will provide Protea access to advanced software for comprehensive protein characterization, PTM analysis, and sequence variant analysis.  We will combine our technologies and workflows with Protein Metrics software to provide novel services to identify, characterize, and quantify biologically important molecules. Biopharma is in need of new bioanalytical capabilities to ensure safety, efficacy and quality of their products".

Chris Becker, President and CEO of Protein Metrics, commented that "the rapid adoption of our suite of software is entirely thanks to the input from our customers who have helped us design tools that are directly applicable and tailored to their needs.  We are delighted to partner with Protea Biosciences and are looking forward to seeing our software advance the results they provide their clients.  We recognize that the industry needs tools allow scientists to analyze data and report knowledge efficiently and confidently.   Because our software is vendor-neutral, we can accept data from any of the mass spectrometry vendors, enabling organizations like Protea to review all of their data on a common platform and share it with their customers in a clear, consistent fashion."  

Protein Metrics has deep experience in protein identification software.  With its current software products and multiple new products to be released shortly, Protein Metrics delivers tools to increase productivity and analytical quality, reduce costs and accelerate development timelines.  Details of Protein Metrics biopharma suite can be found at www.proteinmetrics.com.  

About Protein Metrics

Protein Metrics Inc. is a privately held company serving biopharmaceutical development professionals. The company focuses on the analysis of mass spectrometric and other analytical data on proteins, peptides and glycans. Seeking to ensure that software to analyze mass spec and other analytical data keeps pace with the rapid advances in instrumentation, Protein Metrics leverages its experience in mass spectrometry, computer science, and bioinformatics to make analytical results more complete, sensitive, accurate, and easier to achieve.  The company is headquartered in San Carlos, California.  For more information, visit www.proteinmetrics.com.

About Protea Biosciences

Protea Biosciences Group, Inc. (OTCQB:PRGB) provides innovative bioanalytical solutions to the pharmaceutical and life science industries by applying the Company's proprietary technology to identify and characterize the proteins, metabolites, lipids and other biologically-active molecules which are the byproducts of all living cells and life forms. Protea is the leader in mass spectrometry imaging services (MSI), providing a revolutionary capability that enables the identification and spatial display of biologically-active molecules in tissue and cells. MSI can be performed without sample preparation, labeling or antibody techniques, thereby integrating for the first time direct identification of molecules with anatomic pathology. visit www.proteabio.com or contact stephen.turner@proteabio.com .

Media Contact:Eric Carlson, Protein Metrics Inc, 6504124210, carlson@proteinmetrics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Protein Metrics Inc



Back to news